Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Did you just say Safety Governance Model?

Posted on May 27th, 2016 by in Pharmacovigilance

We usually tend to think that our overall compliance to regulations and fulfilling our ethical commitment to patient safety is best answered through an established set of Policies and SOPs. We design processes around regulatory mandates and adjust to the complexity of the enterprise as much as we can, feeling confident that all our bases are covered. Continue reading “Did you just say Safety Governance Model?” »

Innovative Repurposing: New Drugs From Old

Posted on May 26th, 2016 by in Chemistry

Re-purposing of drugs is fraught with challenges, but can they be overcome so that patients benefit? The term re-purposing is often associated with the idea of saving a few bucks by taking something old and turning it into something useful (like transforming an empty wine bottle into a bird feeder). In the pharmaceutical world, though Continue reading “Innovative Repurposing: New Drugs From Old” »

Driving R&D Success: Deeper Science, Greater Collaboration

Posted on May 25th, 2016 by in Pharma R&D

As a senior strategic marketing professional at Elsevier, I often find myself telling our potential clients: to unlock your organization’s productivity, you need to strengthen your science—and we can help you do that. Continue reading “Driving R&D Success: Deeper Science, Greater Collaboration” »

Embracing and Releasing the Power of Data

Posted on May 24th, 2016 by in Pharma R&D

Big data have huge potential in pharmaceutical research, especially now that the technology to manage, mine and assess the vast amount of available information is catching up with the reality of researchers’ needs. Where it once would have taken many months to effectively trawl Continue reading “Embracing and Releasing the Power of Data” »

  1. 1
  2. 2
  3. 3